114 related articles for article (PubMed ID: 186219)
1. Hormonal variations in secondary amenorrhoea during the metyrapone test.
Mazzi C; Riva LP; Bernasconi D
Clin Endocrinol (Oxf); 1976 Sep; 5(5):531-7. PubMed ID: 186219
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
[TBL] [Abstract][Full Text] [Related]
3. [Proceedings: Effect of synthetic LH-RH on blood LH, FSH and estrogens, pregnanediol or pregnanetriol in urine in various phases of normal menstrual cycle].
Saito M; Kumasaka T; Nichi N; Kato K; Yaoi Y
Arch Gynakol; 1973 Sep; 214(1):411-4. PubMed ID: 4592025
[No Abstract] [Full Text] [Related]
4. The hypothalamic-pituitary-gonadal and adrenal cortical function in adult women with Down's syndrome.
Bock JE
Acta Obstet Gynecol Scand Suppl; 1974; 29():69-72. PubMed ID: 4276259
[No Abstract] [Full Text] [Related]
5. Effect of epimestrol on gonadotropin and prolactin plasma levels and response to luteinizing hormone-releasing hormone/thyrotropin-releasing hormone in secondary amenorrhea and oligomenorrhea.
Genazzani AR; Facchinetti F; de Leo V; Picciolini E; Franchi F; Parrini D; Kicovic PM
Fertil Steril; 1978 Dec; 30(6):654-60. PubMed ID: 153243
[TBL] [Abstract][Full Text] [Related]
6. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the luteinizing hormone releasing hormone (LH-RH) test in patients with secondary amenorrhoea.
Henderson SR; Bonnar J; Souka AR; Bogie W; MacKinnon P; Mattock J; Dutton A
Br J Obstet Gynaecol; 1976 Apr; 83(4):307-14. PubMed ID: 773418
[TBL] [Abstract][Full Text] [Related]
8. Hormonal responses to synthetic luteinizing hormone and follicle stimulating hormone-releasing hormone in man.
Besser GM; McNeilly AS; Anderson DC; Marshall JC; Harsoulis P; Hall R; Ormston BJ; Alexander L; Collins WP
Br Med J; 1972 Jul; 3(5821):267-71. PubMed ID: 4339974
[TBL] [Abstract][Full Text] [Related]
9. Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase.
Sherman BM; Korenman SG
J Clin Endocrinol Metab; 1974 Jul; 39(1):145-9. PubMed ID: 4835128
[No Abstract] [Full Text] [Related]
10. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
11. Plasma hormone profile in anovulation.
Wu CH; Mikhail G
Fertil Steril; 1979 Mar; 31(3):258-66. PubMed ID: 571358
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing the dynamics of gonadotropin response following bolus infusion of luteinizing hormone-releasing factor in women with menstrual abnormalities.
Cantor B; Kalra PS; Buhi WC; Birk SA; Spellacy WN
Fertil Steril; 1977 May; 28(5):526-30. PubMed ID: 323072
[TBL] [Abstract][Full Text] [Related]
13. The significance of FSH elevation in young women with disorders of ovulation.
O'Herlihy C; Pepperell RJ; Evans JH
Br Med J; 1980 Nov; 281(6253):1447-50. PubMed ID: 6777022
[TBL] [Abstract][Full Text] [Related]
14. Effect of ACTH and metyrapone on estriol, 17-hydroxycorticosteroid, 17-ketosteroid, pregnanediol and pregnanetriol excretion late in pregnancy.
Dickey RP; Thompson JP
J Clin Endocrinol Metab; 1969 May; 29(5):701-6. PubMed ID: 4305618
[No Abstract] [Full Text] [Related]
15. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
16. Plasma gonadotrophin levels in ovulatory and anovulatory patients.
Pepperell RJ; Burger HG; deKretser DM; Rennie GC
Br J Obstet Gynaecol; 1976 Jan; 83(1):68. PubMed ID: 1252379
[TBL] [Abstract][Full Text] [Related]
17. Serum prolactin and gonadotrophin levels before and after luteinizing hormone-releasing hormone in the investigation of amenorrhoea.
Bergh T; Nillius SJ; Wide L
Br J Obstet Gynaecol; 1978 Dec; 85(12):945-56. PubMed ID: 367427
[TBL] [Abstract][Full Text] [Related]
18. [Blockade of LH and FSH peaks by low doses of exogenous progesterone in the human female (author's transl)].
Netter A; Gorins A; Thomas K; Cohen M; Joubinaux J
Ann Endocrinol (Paris); 1973; 34(4):430-5. PubMed ID: 4779738
[TBL] [Abstract][Full Text] [Related]
19. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17 beta, luteinizing hormone, follicle-stimulating hormone, and progesterone. I. Probit analysis. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
Am J Obstet Gynecol; 1980 Oct; 138(4):383-90. PubMed ID: 6775535
[TBL] [Abstract][Full Text] [Related]
20. Effects of continuous daily administration of 0.5 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone, pregnanediol and total oestrogens.
Larsson-Cohn U; Johansson ED; Wide L; Gemzell C
Acta Endocrinol (Copenh); 1970 Feb; 63(2):216-24. PubMed ID: 5468622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
